King Charles III left the London Clinic following prostate surgery last Friday and spending three nights in hospital. His Majesty returned to his residence Buckingham Palace, accompanied by his queen consort Camilla.
King Charles was expected to spend just two nights in hospital after his scheduled surgery. A source close to the royal family told The Sun newspaper that it is understood that Charles would only stay in hospital for more than two nights if some kind of unforeseen problem arose.
NEW: King Charles has left hospital after his surgery.— Chris Ship (@chrisshipitv) January 29, 2024
He did not reply to questions about how he is feeling.
He will stay in London tonight as he continues his recuperation. pic.twitter.com/dIE2gU3tdX
Buckingham Palace had announced that the King may take a break from public engagements after resigning from the London Clinic. His Majesty could remain at rest for about a month, according to those in the know. But nothing official at the moment.
Charles III received a visit from Queen Camilla. Now that the sovereign cannot fulfill his duties, it is the King's wife, supported by the heir to the throne William, who replaces him in public commitments.
Great to see King Charles on good form after his short stay in Hospital ? pic.twitter.com/7yuEqomCRk— Chris Jackson (@ChrisJack_Getty) January 29, 2024
Benign prostatic hyperplasia
Benign prostatic hyperplasia is a condition characterized by the increase in volume of the prostate gland. It is not a malignant neoplasm.
In fact, the increase in volume is not due to hypertrophy, but to a hyperplasia of the parenchymal and stromal component of the gland. Even if both conditions involve a global volumetric increase, the term hypertrophy indicates the increase in volume of the individual cells making up an organ, which keep their number unchanged, while hyperplasia indicates the increase in the number of cells.
In this case the increase in the number of cells takes place in the central area of the prostate, which is in contact with the prostatic urethra, or in the periurethral glands and in the transition zone.
It generally begins with the development of microscopic nodules made up mainly of stromal and parenchymal elements, which over the years, increasing in number and size, compress and distort the prostatic urethra producing an obstruction that hinders the flow of urine.